Patents Assigned to Medimush Aps
  • Publication number: 20110045026
    Abstract: A process is described for the production of an immunostimulant by submerged cultivation of Lentinus edodes in which mycelium from agar plates or a fermentation broth is added to a liquid medium in a shake flask or a bioreactor containing nutrients such as malt extract, yeast extract, peptone and glucose having access to air or to which air is added, and which is kept in constant movement at approx. 28° C. At the proper conditions, there will be an increase in the production of extracellular lentinan, which is shown to be a better immunostimulant than intracellular lentinan. The extracellular product is precipitated from the growth medium by means of methods for the precipitation of microbial polysaccharide.
    Type: Application
    Filed: October 1, 2010
    Publication date: February 24, 2011
    Applicant: MEDIMUSH APS
    Inventors: Bjoern Kristiansen, David Waddell
  • Publication number: 20060013825
    Abstract: The present invention relates to compositions comprising polypeptides and polysaccharides. The compositions are in general immune modulating. The invention also discloses methods of producing these compositions using filamentous fungi cultivated in liquid medium. The compositions are useful for example in the treatment of immune compromised conditions.
    Type: Application
    Filed: July 16, 2004
    Publication date: January 19, 2006
    Applicant: MediMush ApS
    Inventor: Bjorn Kristiansen
  • Publication number: 20050163800
    Abstract: A process is described for the production of an immunostimulant by submerged cultivation of Lentinus edodes in which mycelium from agar plates or a fermentation broth is added to a liquid medium in a shake flask or a bioreactor containing nutrients such as malt extract, yeast extract, peptone and glucose having access to air or to which air is added, and which is kept in constant movement at approx. 28° C. At the proper conditions, there will be an increase in the production of extracellular lentinan, which is shown to be a better immunostimulant than intracellular lentinan. The extracellular product is precipitated from the growth medium by means of methods for the precipitation of microbial polysaccharide.
    Type: Application
    Filed: September 3, 2002
    Publication date: July 28, 2005
    Applicant: Medimush Aps
    Inventors: Bjoern Kristiansen, David Waddell